MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Medtronic is making its ‘artificial lung’ therapy available for COVID-19 treatment

Medtronic is making its ‘artificial lung’ therapy available for COVID-19 treatment

By

Medtronic Affinity CP centrifugal blood pump COVID-19 coronavirus artificial lung
The Medtronic Affinity CP centrifugal blood pump [Image courtesy of Medtronic]
Medtronic (NYSE:MDT) is temporarily modifying product indications so that health providers can use its extracorporeal membrane oxygenation (ECMO) technology to treat people with severe cases of COVID-19.

ECMO could be described as a type of “artificial lung” technology that pumps blood from a person’s body to an oxygenator that provides long-term oxygen and carbon-dioxide transfer. Medtronic has devices that are FDA-cleared for extracorporeal support of up to 6 hours — an appropriate amount of time for cardiopulmonary bypass procedures.

Get the full story on our sister site Medical Design & Outsourcing.

More recent news

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].